Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2003
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1463977A Process for extracting amygdalin and use thereof
12/31/2003CN1463748A A novel highly effective immunologic adjuvant originated from plants, method for making the same and use thereof
12/31/2003CN1463744A A health food possessing immunity regulating function and method for preparing the same
12/31/2003CN1463703A Nasal cavity preparation for treating long-term allergic reaction coryza
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132630C Vaccine adjuvants
12/31/2003CN1132629C Composition of tyrosine and polymerised allergen
12/31/2003CN1132628C 多价在卵内接种的禽疫苗 Multivalent in ovo vaccination of poultry vaccines
12/31/2003CN1132623C Compound Chinese medicine prepn. containing Jisongrong and Its prepn process
12/31/2003CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2488856A1 Packaged virus-like particles for use as adjuvants: method of preparation and use
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670391 For inhibiting both immediate and delayed type allergic reactions; side effect reduction
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670377 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669947 Stratified and cryogenically stored vaccines, process for their preparation
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2224663C Animal feed compositions and uses of triterpenoid saponin obtained from camellia l. plants
12/30/2003CA2102241C Use of macrolide compounds for eye diseases
12/30/2003CA2099970C Composition for curing sjoegren syndrome disease
12/30/2003CA2093806C Method of treating or preventing type 1 diabetes by oral administration of insulin
12/25/2003WO2003106424A1 Process for the manufacture of quinoline derivatives
12/25/2003WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236297 Immunosuppressants; autoimmune diseases
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030235626 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
12/25/2003US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235569 Feed additives for chickens
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106498A2 Agonistic binding molecules to the human ox40 receptor
12/24/2003WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus
12/24/2003WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003WO2003106433A1 Deoxyhypusine-synthase inhibitors, pharmaceuticals comprising said inhibitors and uses thereof
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106426A1 Compounds, compositions, and methods
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003106417A1 Mitotic kinesin inhibitors
12/24/2003WO2003106411A1 24-sulfoximine vitamin d3 compounds
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/24/2003WO2003105893A2 Probiotic therapies
12/24/2003WO2003105885A1 Novel method of screening
12/24/2003WO2003105874A1 Thymic epithelial cells with progenitor capacity
12/24/2003WO2003105859A1 Powdery respiratory tonic composition
12/24/2003WO2003105856A1 Combination of azelastine and steroids
12/24/2003WO2003105816A1 Method of treating rosacea by topical application of a cyclohexane derivative
12/24/2003WO2003105811A2 Controlled release compositions and methods for using same
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
1 ... 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 ... 1172